v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
OPERATING EXPENSES        
General and administrative $ 3,470,104 $ 2,331,283 $ 8,833,214 $ 7,624,984
Research and development 2,480,961 1,492,881 7,675,014 4,336,576
Research and development, Vera acquisition 2,888,029   2,888,029  
TOTAL OPERATING EXPENSES 8,839,094 3,824,164 19,396,257 11,961,560
LOSS FROM OPERATIONS (8,839,094) (3,824,164) (19,396,257) (11,961,560)
OTHER INCOME (EXPENSE)        
Interest expense (3,074) (1,573) (19,271) (3,226)
Interest income 2,054   11,520  
Change in fair value of warrant liabilities 215,547 (285,284) 936,256 (909,474)
Equity in losses on equity method investment (37,215) (101,238) (98,754) (218,589)
Other income (expense) (1,087) 412,371 315,637 409,141
Total other income (expenses), net 176,225 24,276 1,145,388 (722,148)
NET LOSS $ (8,662,869) $ (3,799,888) $ (18,250,869) $ (12,683,708)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.29) $ (0.18) $ (0.72) $ (0.69)
WEIGHTED AVERAGE SHARES OUTSTANDING:        
BASIC AND DILUTED 30,092,493 21,193,387 25,482,082 18,441,961

Source